To improve Federal efforts with respect to the prevention of maternal mortality, and for other purposes.

Section 8 increases excise taxes on cigarettes and establishes tax parity among all tobacco products, raising rates for small cigarettes from $50.33 to $100.66 per thousand, large cigarettes from $105.69 to $211.38 per thousand, roll-your-own tobacco from $24.78 to $49.56 per pound, pipe tobacco from $2.8311 cents to $49.56 per pound, smokeless tobacco from $1.51 to $26.84 per pound, and adds new taxes on discrete single-use units and cigars. These are clear cost increases on tobacco manufacture

Section 3(b) expands Medicaid and CHIP coverage for pregnant and postpartum women, including requiring 12-month continuous coverage, oral health services, and enhanced FMAP rates. Section 3(a) funds State-Based Perinatal Quality Collaboratives. Section 3(c) creates Regional Centers of Excellence. Section 4 establishes grants for doula workforce. Section 5 funds rural obstetric mobile health units. These provisions increase funding and service requirements for hospitals and health systems providi

Section 3(b)(1)(A)(ii) adds oral health services for pregnant and postpartum women to Medicaid coverage, which includes diagnostic, periodontal, and restorative care. This expands dental services that may involve pharmaceuticals (e.g., antibiotics, analgesics) used in dental treatment, benefiting pharmaceutical manufacturers.

Section 3(b) expands Medicaid and CHIP coverage for pregnant and postpartum women, including requiring 12-month continuous coverage of full benefits. While Medicaid is public, the expansion increases enrollment in managed care plans that administer Medicaid benefits, benefiting private health insurers that contract with states to provide Medicaid managed care.

Section 3(c) establishes Regional Centers of Excellence addressing implicit bias and cultural competency in patient-provider interactions, with eligibility including entities focused on prevention/treatment/recovery of health conditions contributing to maternal mortality. This could fund biotech research related to maternal health biomarkers, diagnostics, or therapeutics (e.g., for preeclampsia, hemorrhage), benefiting biotech firms.

Section 3(b) extends Medicaid postpartum coverage from 60 days to 12 months, which may increase utilization of postpartum care services that could include home health and community-based services, potentially benefiting long-term care providers offering postpartum support. However, this is indirect and less certain than other tags.